03:24 AM EST, 11/19/2025 (MT Newswires) -- Thomas Trimarchi, President and Chief Financial Officer, on November 16, 2025, sold 16,934 shares in BridgeBio Pharma ( BBIO ) for $1,125,404. Following the Form 4 filing with the SEC, Trimarchi has control over a total of 382,830 common shares of the company, with 382,830 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000147083125000351/xslF345X05/wk-form4_1763512137.xml